Switching to dolutegravir-based two-drug regimens (DTG-2DR): performance in clinical practice

被引：0
|
作者：
Hart, J. [1 ]
Katiyar, A. [1 ]
Smith, C. [2 ]
Hunter, A. [1 ]
Burns, F. [1 ]
Youle, M. [1 ]
Barber, T. J. [1 ]
机构：
[1] Royal Free London NHS Fdn Trust, London, England
[2] UCL, London, England
来源：
HIV MEDICINE | 2020年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P18
引用
收藏
页码：21 / 22
页数：2
相关论文
共 31 条
  • [1] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, Conor
    Ambrose, Alissa
    Simoes, Pedro
    Florman, Katia
    Kanitkar, Tanmay
    Katiyar, Abhishek
    Hunter, Alan
    Hart, Jennifer
    Barber, Tristan
    HIV MEDICINE, 2022, 23 : 24 - 24
  • [2] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, C.
    Ambrose, A.
    Simoes, P.
    Florman, K.
    Kanitkar, T.
    Katiyar, A.
    Hunter, A.
    Hart, J.
    Barber, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 94 - 95
  • [3] REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS
    Garris, C.
    Dhir, S.
    Waller, J.
    Roberts, J.
    Mycock, K.
    Oglesby, A.
    Collins, B.
    Dominguez, M.
    Pike, J.
    Mrus, J. M.
    VALUE IN HEALTH, 2019, 22 : S195 - S195
  • [4] Real-World Experience with Dolutegravir-Based Two-Drug Regimens
    Ward, Douglas
    Ramgopal, Moti
    Riedel, David J.
    Garris, Cindy
    Dhir, Shelly
    Waller, John
    Roberts, Jenna
    Mycock, Katie
    Oglesby, Alan
    Collins, Bonnie
    Dominguez, Megan
    Pike, James
    Mrus, Joseph
    AIDS RESEARCH AND TREATMENT, 2020, 2020
  • [5] Effectiveness and safety of dolutegravir-based two-drug regimens in a multicentre cohort in Spain
    Alejos, B.
    Suarez-Garcia, I.
    Martin-Carbonero, L.
    Moreno-Zamora, A.
    Font, R.
    Portilla, J.
    Martinez, O.
    Omar, M.
    Vinuesa, D.
    Moreno Guillen, S.
    Jarrin, I.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 91 - 92
  • [6] Discontinuation of dolutegravir (DTG)-based regimens in clinical practice
    Vivancos-Gallego, Maria J.
    Moreno, Ana
    Perez-Elias, Maria J.
    Gomez Ayerbe, Cristina
    Luis Casado, Jose
    Quereda, Carmen
    Sanchez-Conde, Matilde
    Serrano Villar, Sergio
    Dronda, Fernando
    Navas, Enrique
    Angel Rodriguez, Miguel
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [7] Experience of dolutegravir/lamivudine (DTG/3TC) and dolutegravir/rilpivirine (DTG/RPV) two-drug antiretroviral regimens in a London tertiary centre
    Hart, J.
    Youle, M.
    Burns, F.
    Barber, T.
    HIV MEDICINE, 2019, 20 : 19 - 19
  • [8] Dolutegravir based two-drug regimen in clinical routine
    Hoeller, Hannes
    Jaeger, Hans
    Jonsson-Oldenbuettel, Celia
    Heldwein, Silke
    Schabaz, Farhad
    von Krosigk, Ariane
    Wiese, Carmen
    Wolf, Eva
    Noe, Sebastian
    INFECTION, 2021, 49 (SUPPL 1) : S11 - S11
  • [9] A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
    Ciccullo, Arturo
    Baldin, Gianmaria
    Capetti, Amedeo
    Rusconi, Stefano
    Sterrantino, Gaetana
    d'Ettorre, Gabriella
    Colafigli, Manuela
    Modica, Sara
    Lagi, Filippo
    Giacomelli, Andrea
    Cossu, Maria Vittoria
    Restelli, Sibilla
    De Luca, Andrea
    Di Giambenedetto, Simona
    ANTIVIRAL THERAPY, 2019, 24 (01) : 63 - 67
  • [10] Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
    Taramasso, Lucia
    Falletta, Antonio
    Ricci, Elena
    Orofino, Giancarlo
    Squillace, Nicola
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Molteni, Chiara
    Pellicano, Giovanni Francesco
    Gulminetti, Roberto
    Madeddu, Giordano
    Sarchi, Eleonora
    Vichi, Francesca
    Celesia, Benedetto Maurizio
    Bonfanti, Paolo
    Di Biagio, Antonio
    VIRUSES-BASEL, 2022, 14 (11):
1234